Cardinal Health raises annual profit outlook as specialty drug demand surges
The drug distributor increased its full-year earnings guidance after beating quarterly estimates today. Strong demand for specialty medicines drove growth.
Insights:
Cardinal Health, Inc. raised its annual adjusted earnings-per-share forecast on February 5, 2026, after reporting quarterly revenue and adjusted earnings per share that beat Wall Street estimates. The company attributed the improved outlook to strong demand for specialty medicines and segment-wide growth across its operations. This guidance update, which signals increased profitability for the year, prompted a premarket share uptick in the US 
US.
US.
